Spark Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Spark Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-51,900	Closed	-$142K	–	836
2017 Q4	$142K	Buy	+51,900	New	+$159K	0.01%	601
2016 Q4	–	Sell	-35,600	Closed	-$119K	–	1001
2016 Q3	$119K	Sell	35,600 -144,100	-80%	-$457K	0.01%	734
2016 Q2	$564K	Buy	+179,700	New	+$599K	0.05%	440
2015 Q2	–	Sell	-79,200	Closed	-$556K	–	838
2015 Q1	$556K	Sell	79,200 -83,800	-51%	-$607K	0.08%	351
2014 Q4	$1.26M	Sell	163,000 -273,800	-63%	-$2.17M	0.21%	157
2014 Q3	$3.26M	Hold	436,800	–	–	0.49%	44
2014 Q2	$4.22M	Sell	436,800 -40,000	-8%	-$357K	0.63%	19
2014 Q1	$3.95M	Sell	476,800 -57,600	-11%	-$494K	0.61%	20
2013 Q4	$4.5M	Buy	534,400 +361,300	+209%	+$3.04M	0.78%	11
2013 Q3	$1.38M	Buy	+173,100	New	+$1.39M	0.32%	90

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Spark Investment Management's PDLI Position: Q1 2018 in Review

Spark Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2018, closing a stake of 51,900 shares — an estimated $142K sold.

Spark Investment Management first reported a position in PDLI in Q3 2013 and held it in 10 quarters. The position peaked at $4.5M in Q4 2013. 176 funds tracked by Wall St. Rank hold PDLI as of Q1 2018.

Spark Investment Management reported no remaining PDL BioPharma, Inc. position as of Q1 2018 after selling out during the quarter.
Spark Investment Management sold 51,900 PDL BioPharma, Inc. shares in Q1 2018, an estimated $142K.
Spark Investment Management first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 10 quarters.
Spark Investment Management's PDL BioPharma, Inc. position peaked at $4.5M in Q4 2013.
176 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2018.

Based on Spark Investment Management's 13F filing for Q1 2018, filed 10 May 2018.